Loading organizations...
§ Private Profile · Tartu, Tartumaa, Estonia
AI-powered radiology software for medical imaging to detect, measure, and classify cancer tumors, assisting radiologists in oncology.
Based in Tallinn, Estonia, Better Medicine develops artificial intelligence-powered radiology software designed to automate the detection, measurement, and classification of cancer tumors in CT scans. The company operates a business-to-business software-as-a-service model, providing its CE-certified medical device, BMVision Kidney, to regional healthcare facilities to improve diagnostic accuracy and streamline clinical workflows for oncologists. Operating with an estimated headcount of under 50 employees, the early-stage enterprise has raised nearly $7 million in total venture funding, which includes a €2.5 million grant from the European Innovation Council. Better Medicine is backed by venture capital firms such as Soulmates Ventures and Superangel, and it deploys its technology across clinical partners including Tartu University Hospital and Leeds Teaching Hospitals NHS Trust. The organization was founded in 2020 by co-founders Priit Salumaa, Dmytro Fishman, Bohdan Drodenko, and Martin Rebane.
Better Medicine has raised $1.2M across 1 funding round.
Better Medicine has raised $1.2M in total across 1 funding round.
Better Medicine has raised $1.2M in total across 1 funding round.
Better Medicine's investors include Michal Sikyta, Specialist VC, UT Ventures.
Better Medicine has raised $1.2M across 1 funding round. Most recently, it raised $1.2M Pre-Seed in August 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 14, 2025 | $1.2M Pre Seed | Michal Sikyta | Specialist VC, UT Ventures | Announced |